SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge

SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge

Coronavirus Disease 2019 (COVID-19), caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has highlighted the need for the rapid generation of efficient vaccines for emerging disease. Virus-like particles, VLPs, are an established vaccine technology that produces vi...

Full description

Bibliographic Details
Main Authors: Edward Sullivan, Po-Yu Sung, Weining Wu, Neil Berry, Sarah Kempster, Deborah Ferguson, Neil Almond, Ian M. Jones, Polly Roy
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Viruses
Subjects:
SARS
COVID-19
coronavirus
baculovirus
VLP
recombinant
Online Access:https://www.mdpi.com/1999-4915/14/5/914

Internet

https://www.mdpi.com/1999-4915/14/5/914

Similar Items